456 related articles for article (PubMed ID: 22531982)
1. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Benamouzig R
Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
3. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
Hassan C; Rex DK; Zullo A; Cooper GS
Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
[TBL] [Abstract][Full Text] [Related]
4. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
Ladabaum U; Song K
Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069
[TBL] [Abstract][Full Text] [Related]
5. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
10. Fecal occult blood testing when colonoscopy capacity is limited.
Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
[TBL] [Abstract][Full Text] [Related]
11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of colonoscopy, based on the appropriateness of an indication.
Hassan C; Di Giulio E; Pickhardt PJ; Zullo A; Laghi A; Kim DH; Iafrate F; Morini S
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1231-6. PubMed ID: 18995214
[TBL] [Abstract][Full Text] [Related]
15. Screening based on risk for colorectal cancer is the most cost-effective approach.
Dan YY; Chuah BY; Koh DC; Yeoh KG
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
[TBL] [Abstract][Full Text] [Related]
16. Propofol, the preferred sedation for screening colonoscopy, is underused. Results of an international survey.
Riphaus A; Macias-Gomez C; Devière J; Dumonceau JM
Dig Liver Dis; 2012 May; 44(5):389-92. PubMed ID: 22119619
[TBL] [Abstract][Full Text] [Related]
17. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
19. Endoscopist-Directed Propofol.
Rex DK
Gastrointest Endosc Clin N Am; 2016 Jul; 26(3):485-92. PubMed ID: 27372772
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
